Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prednisolone pharmacokinetics compared between night and day in asthmatic and normal subjects.

Literature DB >> 7194101

Prednisolone pharmacokinetics compared between night and day in asthmatic and normal subjects.

W A McAllister, D M Mitchell, J V Collins.

Abstract

Entities: Chemical

Mesh：

Substances：
Prednisolone

Year: 1981 PMID： 7194101 PMCID： PMC1401628 DOI： 10.1111/j.1365-2125.1981.tb00538.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

10 in total

1. DIURNAL VARIATION IN SUPPRESSION OF ADRENAL FUNCTION BY GLUCOCORTICOIDS.

Authors: T NICHOLS; C A NUGENT; F H TYLER
Journal: J Clin Endocrinol Metab Date: 1965-03 Impact factor: 5.958

2. Endometriosis involving the rectum and rectosigmoid.

Authors: W A DAY
Journal: Rocky Mt Med J Date: 1962-05

3. A radioimmunoassay method for prednisolone: comparison with the competitive protein binding method.

Authors: J Chakraborty; J English; V Marks; M C Dumasia; D J Chapman
Journal: Br J Clin Pharmacol Date: 1976-10 Impact factor: 4.335

4. Temporal variations of antipyrine half-life in man.

Authors: E S Vesell; C A Shively; G T Passananti
Journal: Clin Pharmacol Ther Date: 1977-12 Impact factor: 6.875

5. Variation in plasma prednisolone concentrations in renal transplant recipients given enteric-coated prednisolone.

Authors: R G Henderson; T Wheatley; J English; J Chakraborty; V Marks
Journal: Br Med J Date: 1979-06-09

6. Dose-dependent prednisolone kinetics.

Authors: A Tanner; F Bochner; J Caffin; J Halliday; L Powell
Journal: Clin Pharmacol Ther Date: 1979-05 Impact factor: 6.875

7. Diurnal rhythms of aminopyrine metabolism: failure to sleep deprivation to affect them.

Authors: G E Poley; C A Shively; E S Vesell
Journal: Clin Pharmacol Ther Date: 1978-12 Impact factor: 6.875

8. Oral prednisone for chronic active liver disease: dose responses and bioavailability studies.

Authors: M Uribe; S W Schalm; W H Summerskill; V L Go
Journal: Gut Date: 1978-12 Impact factor: 23.059

9. Therapeutic utilization of the diurnal variation in pituitary-adrenocortical activity.

Authors: E J Segre; E L Klaiber
Journal: Calif Med Date: 1966-05

10. Diurnal variation of prednisolone binding to serum corticosteroid-binding globulin in man.

Authors: A Angeli; R Frajria; R De Paoli; D Fonzo; F Ceresa
Journal: Clin Pharmacol Ther Date: 1978-01 Impact factor: 6.875

10 in total

11 in total

Prednisolone pharmacokinetics compared between night and day in asthmatic and normal subjects.

1. DIURNAL VARIATION IN SUPPRESSION OF ADRENAL FUNCTION BY GLUCOCORTICOIDS.

2. Endometriosis involving the rectum and rectosigmoid.

3. A radioimmunoassay method for prednisolone: comparison with the competitive protein binding method.

4. Temporal variations of antipyrine half-life in man.

5. Variation in plasma prednisolone concentrations in renal transplant recipients given enteric-coated prednisolone.

6. Dose-dependent prednisolone kinetics.

7. Diurnal rhythms of aminopyrine metabolism: failure to sleep deprivation to affect them.

8. Oral prednisone for chronic active liver disease: dose responses and bioavailability studies.

9. Therapeutic utilization of the diurnal variation in pituitary-adrenocortical activity.

10. Diurnal variation of prednisolone binding to serum corticosteroid-binding globulin in man.

1. Influence of the time of administration of dexamethasone 0.25 mg on cortisol secretion in normal humans.

Review 2. Clinical pharmacokinetics of prednisone and prednisolone.

3. Diurnal variation in cyclosporine kinetics.

4. Influence of pharmacokinetic diurnal variation on bioavailability estimates.

Review 5. Circadian changes of drug disposition in man.

6. Pharmacokinetics of theophylline in night-workers.

Review 7. Chronopharmacology of glucocorticoids.

8. Alterations in prednisolone disposition as a result of time of administration, gender and dose.

9. Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm.

10. Effect of naloxone on circadian rhythms in lung function.